Diabeloop announced that its DBLG2 automated insulin delivery algorithm is now open for prescription with Dexcom G7 and .

A TYPE 1 diabetes drug about to be offered on the NHS is the biggest medical breakthrough against the condition since insulin a century ago, say experts. Teplizumab is given through a drip every day ...

ATLANTA, May 19, 2026 /PRNewswire/ -- Glytec, the leading provider of a glycemic management technology platform for hospitals and health systems, today announced that a joint research team with ...

About a decade ago, a group of competitive CrossFitters in Charleston, South Carolina, went looking for ways to improve their athletic performance without taking steroids. At the time, members of the ...

Glytec, the creator of GlytecOne, a single insulin management platform designed to support safe, consistent glycemic care across patients, acuity levels, and roles, has announced plans to move its ...

A bipartisan quartet of of senators on Wednesday unveiled legislation to cap the monthly cost of insulin at $35 for patients on private insurance. Sens. Jeanne Shaheen (D-N.H.), Susan Collins (R-Maine ...

For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug before it could work—forcing millions of patients to rely on daily injections.

Unexplained hyperglycemic episodes in patients with type 1 diabetes (T1D) who are using automated insulin delivery (AID) systems may be a sign of undetected occlusions, new data showed. In addition, ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Unomedical, a subsidiary of Convatec and a supplier of ...

BOSTON, Sept. 16, 2025 /PRNewswire/ -- Glytec, the leading provider of an AI-powered diabetes platform for hospitals and health systems, today announced that Healthcare Tech Outlook named Glytec its ...